M&T Bank Corp Dice Therapeutics, Inc. Transaction History

M&T Bank Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$19.77 - $42.23 $154,601 - $330,238	7,820 Added 84.07%	17,122 $534,000
Q4 2022 Feb 13, 2023	SELL	$19.77 - $42.23 $379,069 - $809,718	-19,174 Reduced 67.33%	9,302 $290,000
Q2 2022 Aug 05, 2022	BUY	$13.19 - $22.1 $375,598 - $629,319	28,476 New	28,476 $442,000
Q1 2022 May 09, 2022	SELL	$14.54 - $25.02 $120,391 - $207,165	-8,280 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$22.41 - $37.54 $10,129 - $16,968	452 Added 5.77%	8,280 $210,000
Q3 2021 Oct 28, 2021	BUY	$31.92 - $37.0 $249,869 - $289,636	7,828 New	7,828 $256,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.